Epidemiologic predictors of pre-treatment CA125 in women with ovarian cancer
Monday, March 30, 2015: 4:38 PM
Continental Ballroom (Hilton Chicago)
K. Terry1, A. Babic2, B. Y. Karlan3, M. T. Goodman4, D. Lambrechts5, F. Heitz6, K. Matsuo7, I. McNeish8 and T. Pejovic9
1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Harvard School of Public Health, Boston, MA, 3Cedars-Sinai Medical Center, Los Angeles, CA, 4University of Hawaii Cancer Center, Honolulu, HI, 5Vesalius Research Center, Leuven, Belgium, 6Kliniken Essen-Mitte, Essen, Germany, 7Kyushu University, Nagoya, Japan, 8MRC/NCRI (Medical Research Council/National Cancer Research Institute), United Kingdom, 9Rogue Valley Medical Center, Medford, OR